-
1 Comment
Pharmarise Holdings Corporation is currently in a long term downtrend where the price is trading 5.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Pharmarise Holdings Corporation's total revenue sank by 0.5% to $13B since the same quarter in the previous year.
Its net income has increased by 36.8% to $182M since the same quarter in the previous year.
Based on the above factors, Pharmarise Holdings Corporation gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3802320006 |
| Dividend Yield | 5.8% |
|---|---|
| Market Cap | 6B |
| Beta | 0.3 |
| PE Ratio | None |
| Target Price | None |
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; and operation of medical malls. It also provides system integration services to pharmaceutical companies; medical IT solutions; and temporary help and employment placement services. The company was incorporated in 1984 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2796.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
